Management Team | Scientific Team | Scientific Advisory Committee
| Albert P. Li, Ph. D., MBA | Arulasanam K. Thilagar, Ph.D. | David Kwok
, Ph.D. | Paul E. Kirby, Ph.D. | Clara Faan, B.Sc. | Ping Jiang-Baucom, Ph. D. | Shambhu K. Roy, Ph.D. | Sid Aaron, Ph.D., DABT. | Angeline A. Lazarus, M.D. | David Eastmond, Ph.D.
David Kwok, Ph.D.,VP, Drug Development
Dr. Kwok graduated from the Undergraduate Pharmacy Program at the University of British Columbia, Canada, in 1984, followed by his M.Sc. and Ph.D. in applied medicinal chemistry in 1991.
He has served in a variety of management and scientific positions at Health Canada from 1991 to 1998, responsible for botanical safety and quality control, antimicrobial drug resistance, and veterinary drug safety laboratory programs.
has been an invited speaker at numerous professional conferences and has contributed to over 30 scientific publications in bioanalytical chemistry applications and drug candidate optimization studies in peer-reviewed journals, poster presentations, and scientific review journals.
David Kwok is a founder and Vice-President of Drug Development at SB ChemTox LLC, Rockville, MD, an analytical chemistry and bioanalytical CRO established with a mission to offer specialized integrative preclinical drug product development services from early discovery studies to preparation of IND package.
Dr. Kwok is also the founder of BRI Biopharmaceutical Research Inc., an affiliated CRO based in Vancouver, BC, Canada, focused on analytical and bioanalytical mass spectrometry assays in support of preclinical drug development studies.